Exploring Innovation and Public Health Priorities Within the Realm of Medical Sociology of India During COVID-19 Pandemic

Abstract

In the context of the ongoing COVID-19 pandemic, the Indian medical innovation ecosystem confronted substantial challenges in meeting the pressing healthcare requirements of the nation. These challenges demand a comprehensive examination to discern the critical issues in Indian Medical Sociology about medical innovations. The primary objective of this study is to assess the intricate interplay between the approaches employed in drug and vaccine development and their consequential effects on affordability and accessibility. Concurrently, it aims to evaluate the efficacy of the existing policy measures affecting social divisions that have emerged because the supply-driven health system has exacerbated. A qualitative research methodology has been adopted for this inquiry, utilising thematic analysis to dissect the intricacies of the Indian medical innovation ecosystem. The study unfurls the following noteworthy discoveries that contribute to a nuanced understanding of the landscape: (a) it becomes evident that the predominant focus within the Indian medical innovation ecosystem revolves around creating affordable medical technologies and pharmaceuticals, often overshadowing the pursuit of cutting-edge advancements. (b) The strategies employed in developing drugs and vaccines exhibit a conspicuous inclination towards products that promise higher profits, subsequently giving rise to issues associated with affordability and accessibility. (c) While policy measures have been implemented with the intent of addressing the concern of affordability, their actual efficacy in ensuring equitable access to medical innovations raises significant doubts. (d) A discernible imbalance emerges between India's industrial and public health priorities, with economic growth overshadowing the imperative of bridging the existing social disparities. These insights collectively underline the imperative for strategic policy interventions, a more balanced approach to development, and establishing a multi-institutional framework. These actions are essential to confront the challenges related to affordability, accessibility and the aggravated social divisions that persist within the ecosystem. The study brings out the indispensable importance of cultivating a socially responsible and all-encompassing medical innovation ecosystem, not only as a means to address the prevailing healthcare challenges but also to foster an environment that guarantees equitable access to transformative medical innovations for all segments of society.